| Title : Prevalence of treated patients with Alzheimer's disease: current trends and COVID-19 impact - Olazaran_2023_Alzheimers.Res.Ther_15_130 |
| Author(s) : Olazaran J , Carnero-Pardo C , Fortea J , Sanchez-Juan P , Garcia-Ribas G , Vinuela F , Martinez-Lage P , Boada M |
| Ref : Alzheimers Res Ther , 15 :130 , 2023 |
| Abstract : Olazaran_2023_Alzheimers.Res.Ther_15_130 |
| ESTHER : Olazaran_2023_Alzheimers.Res.Ther_15_130 |
| PubMedSearch : Olazaran_2023_Alzheimers.Res.Ther_15_130 |
| PubMedID: 37537656 |
| Title : VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome - Lleo_2021_Alzheimers.Res.Ther_13_119 |
| Author(s) : Lleo A , Carmona-Iragui M , Videla L , Fernandez S , Benejam B , Pegueroles J , Barroeta I , Altuna M , Valldeneu S , Xiao MF , Xu D , Nunez-Llaves R , Querol-Vilaseca M , Sirisi S , Bejanin A , Iulita MF , Clarimon J , Blesa R , Worley P , Alcolea D , Fortea J , Belbin O |
| Ref : Alzheimers Res Ther , 13 :119 , 2021 |
| Abstract : Lleo_2021_Alzheimers.Res.Ther_13_119 |
| ESTHER : Lleo_2021_Alzheimers.Res.Ther_13_119 |
| PubMedSearch : Lleo_2021_Alzheimers.Res.Ther_13_119 |
| PubMedID: 34183050 |
| Title : Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid - Lleo_2019_Mol.Cell.Proteomics_18_546 |
| Author(s) : Lleo A , Nunez-Llaves R , Alcolea D , Chiva C , Balateu-Panos D , Colom-Cadena M , Gomez-Giro G , Munoz L , Querol-Vilaseca M , Pegueroles J , Rami L , Llado A , Molinuevo JL , Tainta M , Clarimon J , Spires-Jones T , Blesa R , Fortea J , Martinez-Lage P , Sanchez-Valle R , Sabido E , Bayes A , Belbin O |
| Ref : Mol Cell Proteomics , 18 :546 , 2019 |
| Abstract : Lleo_2019_Mol.Cell.Proteomics_18_546 |
| ESTHER : Lleo_2019_Mol.Cell.Proteomics_18_546 |
| PubMedSearch : Lleo_2019_Mol.Cell.Proteomics_18_546 |
| PubMedID: 30606734 |